Also they are getting paid in shares. They get more shares if the price is lower. So yea it makes absolute sense they don’t want to pump the price up yet. They would miss out on getting more shares prior to any big announcement.

I’m just saying there is plenty of reasons they could sit on the info and once again nobody said anything about NDAs with the FDA you did. Call the FDA let me know what they say about the clinical hold…. They don’t have any NDAs so ask them.